Retraction: Safety and Efficacy of Tramadol in the Treatment of Premature Ejaculation: A Double-blind, Placebo-Controlled, Fixed-Dose, Randomized Study (Journal of Clinical Psychopharmacology (2006) 26 (27-31) DOI: 10.1097/01.jcp.0000195110.79027.3f);Safety and efficacy of tramadol in the treatment of premature ejaculation: A double-blind, placebo-controlled, fixed-dose, randomized study

Journal of Clinical Psychopharmacology

Volumn 26, Issue 1, 2006, Pages 27-31

  Safarinejad, Mohammad Reza ^a,b   Hosseini, Seyyed Yoosof ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SEROTONIN AGONIST; TRAMADOL;

ADULT; ANAMNESIS; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PLANNING; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NAUSEA; PHYSICAL EXAMINATION; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; VOMITING;

EID: 31544460101     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000001538     Document Type: Erratum

References (42)

1. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine HCl as needed: two single-blind placebo controlled crossover studies. J Urol. 1999;161:1826-1830.
2. Nettelbladt P, Uddenberg N. Sexual dysfunction and sexual satisfaction in 58 married Swedish men. J Psychosom Res. 1979;23:141-147.
3. Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in 'normal' couples. N Engl J Med. 1978;299:111-115.
4. Aycock J. The medical management of premature ejaculation. J Urol. 1942;62:361-362.
5. Remy L. The effect of selective 5HT reuptake inhibitors on 5-methoxy-N, N-dimethyltriptamine induced ejaculation in the rat. Br J Pharmacol. 1986;87:639-648.
6. Baldesarani RJ, Mars E. Fluoxetine and side effects. Arch Gen Psychiatry. 1990;47:191-192.
7. Pollack MH, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med. 1992;22:305-327.
8. Xin ZC, Chung WS, Choi YD, et al. Penile sensitivity in patients with primary premature ejaculation. J Urol. 1996;156:979-981.
9. Atikeler MK, Decit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia. 2002;34:356-359.
10. Lintz W, Barth H, Osterloh G. Bioavailability of enteral tramadol formulations. 1st Communication: capsules. Arzneimittel-Forschung. 1986;36:1278-1283.
11. Lee CR, McTavish D, Sorkin EM. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs. 1993;46:313-340.
12. Lintz W, Erlacin S, Frankus E, et al. Biotransformation of tramadol in man and animal [in German]. Arzneimittel-Forschung. 1981;31:1932-1943.
13. Lintz W, Beier H, Gerloff J. Bioavailability of tramadol after I.M. injection in comparison to I.V. infusion. Int J Clin Pharmacol Ther. 1999;37:175-183.
14. Frink MC, Hennies HH, Englberger W, et al. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung. 1996;46:1029-1036.
15. Marcou TA, Marque S, Mazoit JX, et al. The median effective dose of tramadol and morphine for postoperative patients: a study of interactions. Anesth Analg. 2005;100:469-474.
16. Altunkaya H, Ozer Y, Kargi E, et al. Comparison of local anaesthetic effects of tramadol with prilocaine or minor surgical procedures. BJA. 2003;90:320-322.
17. Jou M, Chu KS, Chen HH, et al. The effects of intrathecal tramadol on spinal somatosensory-evoked potentials and motor-evoked responses in rats. Anesth Analg. 2003;96:783-788.
18. Ludovico GM, Corvasce A, Pagliarulo G, et al. Paroxetine in the treatment of premature ejaculation. BJU. 1996;77:881-882.
19. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-830.
20. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res. 2003;15:309-313.
21. Fleiss J. The Design and Analysis of Clinical Experiments. New York, NY: John Wiley & Sons Inc.; 1986:49-51.
22. Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol. 2001;21:293-297.
23. Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol. 2003;23:467-470.
24. Ahlenius S, Larsson K, Svensson L, et al. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav. 1981;15:785-792.
25. Szele FG, Murphy DL, Garrick NA. Effects of fenfluramine, m-chlorophenylpiperazine and other serotonin-related agonists and antagonists on penile erections in non-human primates. Life Sci. 1988;43:1297-1303.
26. 1A receptor. Eur J Neurosci. 1989;214(suppl 2):121.
27. 1B receptor agonists. Br J Pharmacol. 1998;125:1733-1743.
28. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43:879-923.
29. 2 receptor in the regulation of sexual performance of male rats. Life Sci. 1989;45:1263-1270.
30. Berendsen H, Broekkamp C. Behavioural evidence for functional interactions between 5-HT receptor sub-types in rats and mice. Br J Pharmacol. 1990;101:667-673.
31. Lintz W, Becker R, Gerloff J, et al. Pharmacokinetics of tramadol and bioavailability of enterai tramadol formulations. 4th Communication: drops (without ethanol). Arzneimittel-Forschung. 2000;50:99-108.
32. Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology. 1999;54:544-547.
33. Mcmahon CG. Treatment of premature ejaculation with sertraline hydrochloride. Int J Impot Res. 1998;10:181-184.
34. Montague DK, Jarow L, Broderick GA, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol. 2004;172:290-294.
35. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs. 2000;60:139-176.
36. Lehmann KA. Tramadol for the management of acute pain. Drugs. 1994;47(suppl 1):19-32.
37. Bamigbade TA, Langford RM. The clinical use of tramadol hydrochloride. Pain Rev. 1998;5:155-182.
38. Rose JB, Finkel JC, Arquedas-Mohs A, et al. Oral tramadol for the treatment of pain of 7-30 days' duration in children. Anesth Analg. 2003;96:78-81.
39. Cossmann M, Kohnen C, Langford R, et al. Tolerance and safety of tramadol use: results of international studies and data from drug surveillance. Drugs. 1997;53(2):50-62.
40. Close BR. Tramadol: does it have a role in emergency medicine?. Emerg Med Australas. 2005;17:73-83.
41. Katz WA. Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases. Curr Opin Rheumatol. 2002;14:63-71.
42. Buccellati C, Sala A, Ballerio R, et al. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxides synthase [abstract]. Eur J Pain. 2000;4:413-415.